Christian Laveille(1), Eric Snoeck(1), Brigitte Lacroix(2), Maria Laura Sargentini-Maier(2), Armel Stockis(2) Dose-response population modeling of the new antiepileptic drug brivaracetam in add-on treatment of partial onset seizures.
|
Emma Boström, Margareta Hammarlund-Udenaes and Ulrika SH Simonsson Blood-brain barrier transport helps explain discrepancies in in vivo potency between oxycodone and morphine
|
M.A. Fabre (2), E. Fuseau (2), A. Vermeulen (1), A. Thyssen (1). Population pharmacokinetic analysis in children, adolescents and adults with schizophrenia or bipolar disorder
|
M. Vernaz-Gris (1), E. Fuseau (1), L. Del Frari (2), V. Brunner (2), P. Hermann (2) Pooled PK analysis of a new CNS drug, in healthy subjects.
|
Bojan Lalovic, Matthew M Hutmacher, Bill Frame, Kaori Ito, Raymond Miller Modeling the Dropout from Longitudinal Adverse Event Data: Selecting Optimal Titration Regimens
|
Gijs Santen(1), Meindert Danhof(1), Oscar Della Pasqua(1,2) Comparing treatment effect in depression trials: Mixed Model for Repeated Measures vs Linear Mixed Model
|
Maria C. Kjellsson (1), Daniele Ouellet (2), Raymond Miller (2), Mats O. Karlsson (1) Modelling Sleep Using Markov Mixed Effects Models
|
L. Iavarone(1), R. Gomeni(1), E. Merlo-Pich(2) Population PK/PD of Alprazolam in the Attenuation of ACTH Activation Induced by Cognitive Performance in Metyrapone-treated Healthy Volunteers
|
Gianluca Nucci, Keith Muir and Roberto Gomeni Population pharmacokinetic modelling of pimozide and its relation to CYP2D6 genotype.
|
Sandra Visser(1), Elke Krekels(1), Kristina Ängeby Möller(2), Marie Angesjö(1), Ingemo Sjögren(1) and Odd-Geir Berge(2) Modeling the time-course of the antipyretic effects and prostaglandin inhibition in relation the analgesic effects of naproxen: a compound selection strategy
|
K. Vucicevic(1), B. Miljkovic(1), M. Pokrajac (1), I. Grabnar(2) Population Pharmacokinetic Modelling of Amitriptyline in Depression Patients
|
F. Larsen (1), C. Bundgaard (2) Non-Linear Mixed Effects PK/PD Modelling of Acute Autoinhibitory Feedback Effects of Escitalopram (ESC) on Extracellular Serotonin (5-HT) Levels in Rat Brain
|
Mathilde Marchand (1, 2), Eliane Fuseau (1), David Critchley (3) Supporting the recommended paediatric dosing regimen for rufinamide using clinical trial simulation
|
Marc-Antoine Fabre, Eliane Fuseau(1), Maria-Laura Sargentini-Maier, Nathalie Toublanc(2) Retrospective population pharmacokinetic analysis of seletracetam in epileptic and healthy adults
|